Selected highlights from the 31^st European Association of Urology Annual Congress

Summary

The 31^st European Association of Urology Annual Congress took place in March 2016 in Munich. In prostate cancer the early use of chemotherapy in addition to androgen deprivation therapy in men with primary metastatic disease is a clinical practice changing concept that needs implementation through collaboration between urologists and medical oncologists.
The role of MRI and fusion biopsies in early detection, diagnosis and active surveillance strategies is becoming more and more important. In bladder cancer, non-urothelial tumour types got a lot of attention and specific treatment strategies were presented. Furthermore, immunological treatment came forward to perhaps replace chemotherapy in the management of advanced urothelial bladder cancer.

(BELG J MED ONCOL 2016;10(6):228–231)